Related Experiment Video

Updated: Aug 10, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Immunogenetic programs for viral induction of mucous cell metaplasia

Michael J Holtzman1, John T Battaile, Anand C Patel

  • 1Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. holtzman@im.wustl.edu

American Journal of Respiratory Cell and Molecular Biology
|March 18, 2006
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Related Experiment Videos

Last Updated: Aug 10, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Articles linked to this work by shared authors, journal, and citation graph.

Myoclonin1 haploinsufficiency in motile ciliated cells partially recapitulates epileptic features of Efhc1-deficient mice in adult age.

Molecular and cellular neurosciences·2026

Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Blood·2026

Charity coverage and decreased COVID-19 mortality among uninsured patients in Texas: A retrospective cohort study.

PloS one·2025

O-GlcNAc transferase plays dual antiviral roles by integrating innate immunity and lipid metabolism.

Nature communications·2025

Choroid plexus apocrine secretion shapes CSF proteome during mouse brain development.

Nature neuroscience·2025

Role of intraflagellar transport protein IFT140 in the formation and function of motile cilia in mammals.

Cellular and molecular life sciences : CMLS·2025

Inhaled vitamin A mitigates hyperoxia-induced acute and chronic lung damage in a neonatal rat model of bronchopulmonary dysplasia.

American journal of respiratory cell and molecular biology·2026

Haptoglobin Protects Against Increased Chlorine Inhalation Vulnerability in Sickle Cell Trait Mice.

American journal of respiratory cell and molecular biology·2026

Poly I:C-induced monocyte-macrophages alleviate type 2 immunopathology in a murine asthma model.

American journal of respiratory cell and molecular biology·2026

Modified RNA Extraction Methods to Eliminate Agarose Impurities in Human Precision-Cut Lung Slices.

American journal of respiratory cell and molecular biology·2026

Consensus Lung Cell Reference: The Collaborative Cross-Consortium and Country Lung Cell Nomenclature Project (C3LCN). An Official American Thoracic Society Workshop Report.

American journal of respiratory cell and molecular biology·2026

GPCR Biology-Informed Drug Discovery in Asthma.

American journal of respiratory cell and molecular biology·2026

DAMPs, PAMPs, and Alarmins: From Mechanism to Therapy.

MedComm·2026

Gut Microbiome Composition and Response to Immune Checkpoint Inhibitors in Melanoma: A Systematic Review.

Cureus·2026

Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selection.

Virus evolution·2026

NF-κB across the Alzheimer disease spectrum: Context-dependent protective and pathogenic roles.

IBRO neuroscience reports·2026

Molecular Investigation of Pro-inflammatory and Anti- Inflammatory Cytokines Gene Expression in Macrophages Exposed to Leishmania major.

Archives of Razi Institute·2026

Exploring the role of TNF/TNFR superfamily and NF-κB pathway in regulating B7/CD28 expression in rheumatoid arthritis: An in-vitro study.

Pakistan journal of pharmaceutical sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us